58 results
Page 2 of 3
6-K
EX-99.2
08lq ws8506j3ds5kd
31 Aug 21
Material Change Report
2:06pm
6-K
EX-99.1
ox9v9jmj95u gta
25 Aug 21
Acquisition Advances Company’s Strategic Plan Toward a Diversified Novel Drug Development Pipeline in Psychedelics and Medical Cannabis
9:00am
6-K
EX-99.1
c5fqc
5 May 21
Current report (foreign)
11:30am
6-K
EX-99.1
w3ze99u3tiuoqfrxv
5 May 21
Current report (foreign)
11:30am
6-K
EX-99.1
1gen41
3 May 21
FSD Pharma Inc. 6-K
7:30am
6-K
EX-99.1
sq46l19
23 Apr 21
Current report (foreign)
5:24pm
F-10
vtn6cqfwan6z7xdew
2 Apr 21
Registration of securities (Canada)
12:49pm
40-F
x6rbysfwrseoash1
17 Mar 21
Annual report (Canada)
12:00am
40-F
EX-99.1
9k6lwmg5m9f
17 Mar 21
Annual report (Canada)
12:00am
SUPPL
qijob x1t0w
11 Feb 21
Supplemental materials (foreign)
8:32am
6-K
EX-99.1
gno5e1
29 Jan 21
Material Change Report
6:00am
6-K
EX-99.1
6wo4x4w
26 Jan 21
FSD Pharma Inc. 6-K
9:20pm
SUPPL
j8odrv
16 Oct 20
Supplemental materials (foreign)
5:19pm
6-K
EX-99.1
eraj7kkt mc6balu7
14 Oct 20
Material Change Report
8:26pm
6-K
EX-99.1
2qyn6inr
29 Sep 20
FSD Pharma Begins Phase 2 Clinical Trial to Evaluate FSD201 for the Treatment of Hospitalized COVID-19 Patients
10:35am
SUPPL
7r4ma9 fwcymtwzu
31 Jul 20
Supplemental materials (foreign)
9:43pm
SUPPL
r3fqjjw3qnoe2x5d
13 Jul 20
Supplemental materials (foreign)
12:00am
F-10/A
jha 4pwbh
16 Jun 20
Registration of securities (Canada) (amended)
9:20pm
6-K
EX-99.1
2gkppdzk
4 Mar 20
Current report (foreign)
4:37pm
40-F
EX-99.1
cixi3guh
4 Mar 20
Annual report (Canada)
12:29pm